help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hartog, C. M.
Right arrow Articles by Braun, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hartog, C. M.
Right arrow Articles by Braun, J.
American Journal of Respiratory and Critical Care Medicine Vol 167. pp. 593-598, (2003)
© 2003 American Thoracic Society


Original Article

Pulmonary Matrix Metalloproteinase Excess in Hospital-acquired Pneumonia

Christine M. Hartog, Johanna A. Wermelt, Carsten O. Sommerfeld, Wolfgang Eichler, Klaus Dalhoff and Joerg Braun

Medizinische Klinik III and Klinik für Anaesthesiologie, Medical University of Lübeck, Lübeck, Germany

Correspondence and requests for reprints should be addressed to Joerg Braun, 1, Medizinische Abteilung des AK Wandsbek, Alphonsstraße 14, 22043 Hamburg, Germany. E-mail: joerg.braun{at}ak-wandsbek.lbk-hh.de

In hospital-acquired pneumonia, extracellular matrix destruction is common and may be caused by excessive activity of matrix metalloproteinases (MMPs). Thirty patients with hospital-acquired pneumonia and 16 control subjects were studied. We evaluated the concentrations of MMP-8, MMP-9, and tissue inhibitor of metalloproteinase-1 in mini-bronchoalveolar lavage fluid (mini-BALF) and blood using zymography and specific immunoassays. In patients with hospital-acquired pneumonia concentrations of MMP-8 and MMP-9 in mini-BALF were increased 10-fold, whereas their specific inhibitor tissue inhibitor of metalloproteinase-1 was not concomitantly increased. In 80% of patients with pneumonia, but in none of the control subjects, the active form of MMP-9 was detected by zymography. Zymography furthermore showed the banding pattern of neutrophil-derived MMP-9, indicating that neutrophils were the main source of MMP-9. Comparison of neutrophils from blood and mini-BALF showed higher basal release of MMPs by pulmonary neutrophils. Stimulation analysis indicated that pulmonary neutrophils were already maximally activated. In patients with detection of potentially pathogenic microorganisms, concentrations of MMPs were fivefold increased compared with patients with negative cultures. Furthermore, MMP-levels were related to clinical severity. These are the first data suggesting that neutrophil-derived MMPs are increased in hospital-acquired pneumonia in association to the detection of causative microorganisms and clinical severity.

Key Words: matrix metalloproteinases • TIMP-1 hospital-acquired pneumonia • polymorphonuclear neutrophils




This article has been cited by other articles:


Home page
Eur Respir JHome page
R. Cockeran, T. J. Mitchell, C. Feldman, and R. Anderson
Pneumolysin induces release of matrix metalloproteinase-8 and -9 from human neutrophils
Eur. Respir. J., November 1, 2009; 34(5): 1167 - 1170.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. L. Ventura, R. Higdon, L. Hohmann, D. Martin, E. Kolker, H. D. Liggitt, S. J. Skerrett, and C. E. Rubens
Staphylococcus aureus Elicits Marked Alterations in the Airway Proteome during Early Pneumonia
Infect. Immun., December 1, 2008; 76(12): 5862 - 5872.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
P T G Elkington and J S Friedland
Matrix metalloproteinases in destructive pulmonary pathology
Thorax, March 1, 2006; 61(3): 259 - 266.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R. H. Hubner, S. Meffert, U. Mundt, H. Bottcher, S. Freitag, N. E. El Mokhtari, T. Pufe, S. Hirt, U. R. Folsch, and B. Bewig
Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation
Eur. Respir. J., March 1, 2005; 25(3): 494 - 501.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Critical Care Medicine in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 239 - 253.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Tuberculosis, Lung Infections, Interstitial Lung Disease, Social Issues and Journalology in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 288 - 300.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. C. Gabazza, O. Taguchi, and Y. Adachi
Do Matrix Metalloproteinases Protect or Worsen Pneumonia?
Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 133 - 133.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society
  Tobacco